NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT00006089 2019-07-31Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerNational Cancer Institute (NCI)Phase 2 Completed34 enrolled